Affiliation:
1. Department of Radiology and Biomedical Imaging UCSF San Francisco California USA
2. Department of Radiological Sciences UCLA Los Angeles California USA
3. Department of Bioengineering UCLA Los Angeles California USA
4. UCSF/UC Berkeley Graduate Program in Bioengineering San Francisco and Berkeley California USA
5. Department of Neurology UCSF San Francisco California USA
Abstract
BackgroundPathophysiological changes of Huntington's disease (HD) can precede symptom onset by decades. Robust imaging biomarkers are needed to monitor HD progression, especially before the clinical onset.PurposeTo investigate iron dysregulation and microstructure alterations in subcortical regions as HD imaging biomarkers, and to associate such alterations with motor and cognitive impairments.Study TypeProspective.PopulationFourteen individuals with premanifest HD (38.0 ± 11.0 years, 9 females; far‐from‐onset N = 6, near‐onset N = 8), 21 manifest HD patients (49.1 ± 12.1 years, 11 females), and 33 age‐matched healthy controls (43.9 ± 12.2 years, 17 females).Field Strength/Sequence7 T, T1‐weighted imaging, quantitative susceptibility mapping, and diffusion tensor imaging.AssessmentVolume, susceptibility, fractional anisotropy (FA), and mean diffusivity (MD) within subcortical brain structures were compared across groups, used to establish HD classification models, and correlated to clinical measures and cognitive assessments.Statistical TestsGeneralized linear model, multivariate logistic regression, receiver operating characteristics with the area under the curve (AUC), and likelihood ratio test comparing a volumetric model to one that also includes susceptibility and diffusion metrics, Wilcoxon paired signed‐rank test, and Pearson's correlation. A P‐value <0.05 after Benjamini–Hochberg correction was considered statistically significant.ResultsSignificantly higher striatal susceptibility and FA were found in premanifest and manifest HD preceding atrophy, even in far‐from‐onset premanifest HD compared to controls (putamen susceptibility: 0.027 ± 0.022 vs. 0.018 ± 0.013 ppm; FA: 0.358 ± 0.048 vs. 0.313 ± 0.039). The model with additional susceptibility, FA, and MD features showed higher AUC compared to volume features alone when differentiating premanifest HD from HC (0.83 vs. 0.66), and manifest from premanifest HD (0.94 vs. 0.83). Higher striatal susceptibility significantly correlated with cognitive deterioration in HD (executive function: r = −0.600; socioemotional function: r = −0.486).Data Conclusion7 T MRI revealed iron dysregulation and microstructure alterations with HD progression, which could precede volume loss, provide added value to HD differentiation, and might be associated with cognitive changes.Evidence Level2Technical EfficacyStage 2
Funder
National Institute of Neurological Disorders and Stroke